Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine
Hideyuki Imagawa,1 Saurabh P Nagar,2 William Montgomery,3 Tomomi Nakamura,1 Masayo Sato,1 Keith L Davis2 1Medical Development Unit Japan, Eli Lilly Japan K.K., Kobe, Japan; 2RTI Health Solutions, Research Triangle Park, NC, USA; 3Global Patient Outcomes and Real World Evidence, Eli Lilly Australia,...
Main Authors: | Imagawa H, Nagar SP, Montgomery W, Nakamura T, Sato M, Davis KL |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-02-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/treatment-patterns-health-care-resource-utilization-and-costs-in-japan-peer-reviewed-article-NDT |
Similar Items
-
Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
by: Joseph A, et al.
Published: (2016-03-01) -
Atomoxetine in the Treatment of the Most Common Comorbid Disorders of Attention-Deficit/Hyperactivity Disorder, Oppositional Defiant Disorder and Anxiety Disorders
by: Snircova E., et al.
Published: (2012-12-01) -
Maculopapular Rash Related to Atomoxetine: Case Report
by: Nurdan Kasar, et al.
Published: (2020-11-01) -
Atomoxetine Induced Seperation Anxiety: A Case Report
by: Gonca Gul Celik, et al.
Published: (2013-06-01) -
Is atomoxetine effective in some comorbid mental disorders in ADHD?
by: Cesneková D., et al.
Published: (2016-09-01)